In Canada, health regulators took one step to fill that gap by approving a generic version of semaglutide, which is the ...

Glucagon-like peptide-1 (GLP-1) receptor agonists may improve cardiovascular outcomes in the year following TAVI for aortic ...

GLP-1 overdoses are on the rise, and some clinicians suggest informing patients of the risk in the initial consultation.

The Centers for Medicare & Medicaid Services will keep its Medicare GLP-1 Bridge program in place through the end of 2027, letting eligible beneficiaries access drugs like Wegovy and Zepbound for a ...

Sarah Kelley says she struggled with her weight for most of her life. “I’ve tried every diet out there since I was a kid,” ...

Ivim Health reports on the effectiveness of GLP-1 pills vs. Ozempic, emphasizing personalized care for obesity management.

Food noise is a genuine phenomenon characterized by a constant preoccupation with food. The causes of food noise are complex ...

A comprehensive 2026 evaluation examining the science behind the gut-based GLP-1 activation formula, analyzing the natural ...

The number of Americans using weight-loss drugs such as Ozempic has increased to about 12.4 percent. Restaurateurs are taking ...

GLP Diet app review pieces are popping up at the same moment interest in Ozempic and other GLP-1 drugs is beginning to cool, ...

A man who lost over 80 pounds before nearly losing his life is sharing his story as a cautionary tale for others seeking ...

By Juliette Cubanski and KFF Health News HealthDay ReportersThe Centers for Medicare & Medicaid Services (CMS) has announced ...